Figure 1From: Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications Percentage utilisation of risperidone (defined daily dose (DDD) basis) versus selected atypical antipsychotic drugs among four European countries. NB. *= No statistical difference in the rate of risperidone utilisation before and after the availability of generic risperidone in separate country analyses.Back to article page